NCT01629706

Brief Summary

The purpose of the study is to investigate the corneal epithelial cell response associated with lens wear that results in solution-induced corneal staining (Phase1) and to determine the cell appearance in symptomatic and asymptomatic contact lens wearers (Phase 2).

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
92

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Sep 2012

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 26, 2012

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 28, 2012

Completed
2 months until next milestone

Study Start

First participant enrolled

September 1, 2012

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 1, 2014

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

February 13, 2015

Completed
Last Updated

March 3, 2015

Status Verified

January 1, 2015

Enrollment Period

1.3 years

First QC Date

June 26, 2012

Results QC Date

January 29, 2015

Last Update Submit

February 12, 2015

Conditions

Outcome Measures

Primary Outcomes (11)

  • Mean Number of Viable Epithelial Cells Collected Directly From the Ocular Surface After 2 Hours and 4 Hours of Wear, Phase 1

    The worn contact lenses were removed and epithelial (corneal) cells were collected directly from the ocular surface using an eyewash. Immediately following the eyewash, samples were taken to a laboratory and incubated with live/ dead stains. The number of viable (alive) cells was counted using a microscope. Cells collected from the right and the left eye were analyzed separately. A significant difference in viable cell count may indicate a physiological response to the contact lens and/or care regimen over time.

    Day 1 after 2 hours of wear; Day 7 after 4 hours of wear

  • Mean Number of Non-Viable Epithelial Cells Collected Directly From the Ocular Surface After 2 Hours and 4 Hours of Wear, Phase 1

    The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash. Immediately following the eyewash, samples were taken to a laboratory and incubated with live/dead stains. The number of non-viable (dead) cells was counted using a microscope. Cells collected from the right and the left eye were analyzed separately. A significant difference in non-viable cell count may indicate a physiological response to the contact lens and/or care regimen over time.

    Day 1 after 2 hours of wear; Day 7 after 4 hours of wear

  • Mean Number of Fluorescein-Stained Epithelial Cells Collected Directly From the Ocular Surface After 2 Hours and 4 Hours of Wear, Phase 1

    The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash. Immediately following the eyewash, samples were taken to a laboratory. The total number of fluorescein-stained cells was counted using a microscope. Cells collected from the right and the left eye were analyzed separately. A significant difference in fluorescein-stained cell count may indicate a physiological response to the contact lens and/or care regimen over time.

    Day 1 after 2 hours of wear; Day 7 after 4 hours of wear

  • Ratio of Epithelial Cells Collected Directly From the Ocular Surface and Cells Collected From the Contact Lens After 2 Hours and 4 Hours of Wear, Phase 1

    The worn contact lenses were removed, rinsed and transferred in individual glass vials. Epithelial cells were collected directly from the ocular surface using an eyewash. Samples were taken to a laboratory and cells collected from each lens and each eye were counted separately using a microscope. The ratio of cells collected from the ocular surface and from the contact lens was calculated. A higher number indicates a higher percentage of cells collected from the contact lenses relative to the total number of cells collected.

    Day 1 after 2 hours of wear; Day 7 after 4 hours of wear

  • Ratio of Viable and Non-Viable Epithelial Cells After 2 Hours and 4 Hours of Wear, Phase 1

    The worn contact lenses were removed, rinsed and transferred in individual glass vials. Epithelial cells were collected directly from the ocular surface using an eyewash. Samples were taken to a laboratory and incubated with live/dead stains. Cells collected from each lens and each eye were counted separately using a microscope. The number of viable and non-viable cells was counted using a microscope. The ratio between viable and non-viable cell counts was calculated. A higher number indicates a higher percentage of non-viable cells relative to the total cell count.

    Day 1 after 2 hours of wear; Day 7 after 4 hours of wear

  • Mean Number of Viable Epithelial Cells Collected Directly From the Ocular Surface at Day 1 and Week 4, Phase 2

    The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash. Immediately following the eyewash, samples were taken to a laboratory and incubated with live/dead stains. The number of viable cells was counted using a microscope. Cells collected from right and left eyes were pooled. Samples were collected after 8 hours of wear. A significant difference in cell count may indicate a physiological response to contact lens wear due to lens age.

    Day 1 and Week 4

  • Mean Number of Non-Viable Epithelial Cells Collected Directly From the Ocular Surface at Day 1 and Week 4, Phase 2

    The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash. Immediately following the eyewash, samples were taken to a laboratory and incubated with live/dead stains. The number of non-viable cells was counted using a microscope. Cells collected from right and left eyes were pooled.Samples were collected after 8 hours of wear. A significant difference in cell count may indicate a physiological response to contact lens wear due to lens age

    Day 1 and Week 4

  • Mean Number of Epithelial Cells Collected From the Contact Lens at Day 1 and Week 4, Phase 2

    The worn contact lenses were removed and transferred into well plates, each containing a soaking solution. Following a soaking duration of approximately 30 minutes, lenses were rinsed and transferred in individual glass vials. The cell content from the lens wash was taken to a laboratory and incubated with live/dead stains. The total number of cells (viable and non-viable) were counted using a microscope. Cells collected from right and left lens were pooled. Samples were collected after 8 hours of wear. A significant difference in cell count may indicate a physiological response to contact lens wear due to lens age.

    Day 1 and Week 4

  • Mean Number of Epithelial Cells Collected Directly From the Ocular Surface at Day 1 and Week 4, Phase 2

    The worn contact lenses were removed and epithelial cells were collected directly from the ocular surface using an eyewash. Immediately following the eyewash, samples were taken to a laboratory and incubated with live/dead stains. The number of cells (viable and non-viable) was counted using a microscope. Cells collected from right and left eyes were pooled. Samples were collected after 8 hours of wear. A significant difference in cell count may indicate a physiological response to contact lens wear due to lens age.

    Day 1 and Week 4

  • Ratio of Epithelial Cells Collected Directly From the Ocular Surface and Cells Collected From the Contact Lens at Day 1 and Week 4, Phase 2

    The worn contact lenses were removed, rinsed and transferred in individual glass vials. Epithelial cells were collected directly from the ocular surface using an eyewash. Samples were taken to a laboratory and cells collected from the right and the left eye were combined; cells collected from the right and the left lens were combined. The ratio of cells collected from the ocular surface and from the contact lens was calculated. A higher number indicates a higher percentage of cells collected from the contact lenses relative to the total number of cells collected.

    Day 1 and Week 4

  • Ratio of Viable and Non-Viable Epithelial Cells at Day 1 and Week 4, Phase 2

    The worn contact lenses were removed, rinsed and transferred in individual glass vials. Epithelial cells were collected directly from the ocular surface using an eyewash. Samples were taken to a laboratory and incubated with live/dead stains. Cells collected from the right and the left eye were combined; cells collected from the right and the left lens were combined. The number of viable and non-viable cells was counted using a microscope. The ratio between viable and non-viable cell counts was calculated. A higher number indicates a higher percentage of non-viable cells relative to the total cell count.

    Day 1 and Week 4

Study Arms (2)

PV+ClearCare / PV+Renu (Phase 1)

EXPERIMENTAL

Balafilcon A contact lens pre-soaked overnight in ClearCare cleaning and disinfecting system worn in 1 eye for two hours and four hours at a time, separate days, with Balafilcon A contact lens pre-soaked overnight in renu multi-purpose solution worn in the fellow eye

Device: Balafilcon A contact lensDevice: Renu multi-purpose solutionDevice: ClearCare

Habitual (Phase 2)

EXPERIMENTAL

Phase 2: Habitual contact lenses worn bilaterally on a daily wear basis for 4 weeks with habitual lens care

Device: Habitual contact lensesDevice: Habitual lens care

Interventions

Commercially marketed silicone hydrogel contact lens

Also known as: PureVision™
PV+ClearCare / PV+Renu (Phase 1)

Commercially marketed silicone hydrogel contact lenses as prescribed by eye care practitioner, brand and power

Habitual (Phase 2)

Commercially marketed solution for use in removing protein, cleaning, conditioning, and disinfecting contact lenses.

Also known as: renu® fresh™
PV+ClearCare / PV+Renu (Phase 1)
ClearCareDEVICE

Commercially marketed hydrogen peroxide system for cleaning and disinfecting contact lenses

Also known as: ClearCare®
PV+ClearCare / PV+Renu (Phase 1)

Lens care per habitual use

Habitual (Phase 2)

Eligibility Criteria

Age17 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Full legal capacity to volunteer.
  • Read and sign an informed consent form.
  • Willing and able to follow instructions and maintain the appointment schedule.
  • Current or previous contact lens wearer and competent to insert and remove contact lenses.
  • Up-to-date spectacles.
  • Full legal capacity to volunteer.
  • Read and sign an informed consent form.
  • Willing and able to follow instructions and maintain the appointment schedule.
  • Up-to-date spectacles.
  • Wears single vision silicone hydrogel contact lenses, following a monthly replacement schedule.
  • Has worn the same lens type for a minimum of 2 months, with the exception of the 2 periods of lens wear for participants who were also in Phase 1.
  • Has used the same type of cleaning solution for a minimum of 2 months.
  • Currently wears brand name contact lenses and uses brand name cleaning solutions that are commercially available in Canada (no private labels).

You may not qualify if:

  • Any ocular disease.
  • Systemic condition that may affect a study outcome variable.
  • Use of any systemic or topical medications that may affect ocular health.
  • Known sensitivity to the diagnostic pharmaceuticals to be used in the study.
  • Presents with significant amounts of corneal staining.
  • Current use of artificial tears and/or rewetting drops.
  • Wears contact lenses on an extended (overnight) or continuous wear schedule.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Refractive ErrorsDry Eye Syndromes

Condition Hierarchy (Ancestors)

Eye DiseasesLacrimal Apparatus Diseases

Results Point of Contact

Title
Alan Landers, Project Head, Vision Care R&D
Organization
Alcon Research, Ltd.

Study Officials

  • Lyndon Jones, FCOptom, PhD

    University of Waterloo School of Optometry and Vision Science

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restriction Type
OTHER
Restrictive Agreement
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 26, 2012

First Posted

June 28, 2012

Study Start

September 1, 2012

Primary Completion

January 1, 2014

Study Completion

January 1, 2014

Last Updated

March 3, 2015

Results First Posted

February 13, 2015

Record last verified: 2015-01